Healthcare & Life Sciences Lawyers
A blend of expertise, a common culture.
The health agenda is the most critical and high profile in society, but its value also brings enormous complexity and challenge.
Its importance to us as a firm is reflected in the scale of our team and the many years of experience that we bring to bear. We pride ourselves on the breadth of that team both in terms of our ability to support the diversity of the sector and the depth of our legal expertise.
From locally provided primary and community care through to large scale infrastructure projects, we have an intimate knowledge of the healthcare system. When combined with our experience in supporting a broad range of activity across the biotech, medical devices and the burgeoning med tech communities, from start-ups to high profile multinationals, our ability to support and guide the health sector client community is market leading.
We advised Bridgepoint Growth I with a capital investment into PharmaReview, a UK provider of compliance and copy review services to the life sciences sector.
We advised Welltower Inc, a global investor in healthcare real estate, in the Scottish aspects of a £540 million refinance of HC-One’s existing debt facilities, involving a UK-wide portfolio of HC-One operated care homes, with around 50 in Scotland.
Hub West Scotland
We are advising Hub West Scotland on a Design and Build Development Agreement for the £50million development for a new North East Health Hub on a site near Parkhead, Glasgow - the largest health centre in Scotland.
Hamberley Care Homes
We are Scottish advisers to Hamberley Care Homes Group, providing a multi-disciplinary service including advice on property, corporate finance, regulatory, banking, construction and employment law.
We've worked with this leading and fast growing US and European Strategic Healthcare and Life Sciences advisory group for over a decade, supporting them on various matters relating to property, employment and acquisitions. Most recently we advised on the restructure and alignment of a number of their business to form a new technology centric division.
We provide ongoing investment advice to Scottish Enterprise, which includes a variety of investments in the life science and healthcare sector. Recent transactions include their participation in a £2.4m funding round into Clinspec Diagnostics (an early cancer detection tech pioneer) and a £1.7m funding round into Cumulus Oncology, Europe’s first oncology drug discovery accelerator.
We advised NHS Lothian on a Design and Build Development Agreement for the £3million refurbishment of the Panmure St Ann's school building into a health and care centre for Edinburgh’s homeless population.
The Wellcome Trust
We advised the Wellcome Trust, a charity dedicated to medical research and new drug discoveries, on the Scots law aspects of its recommended public takeover of Urban&Civic plc, a regeneration-focused property development company.
Highlands & Islands Enterprise
We are advising Highlands & Islands Enterprise on the procurement and construction of the Life Sciences Innovation Centre, consisting of a teaching and research facility for the University of the Highlands & Islands and commercial space for Highlands & Islands Enterprise.
We advised Aedifica, a pan European Healthcare REIT, on the Scots law aspects of the acquisition of a substantial UK care home portfolio comprising 92 care homes, of which 10 were located in Scotland.
We advised a US based MedTech company that has pioneered unique medical devices and therapies in relation to a strategic alliance and consulting agreement with a leading Scottish University.
Latest news, insights and upcoming events
Insights- 21st September 2021
Migration policy is an area of government decision-making that has a very wide impact.
Insights- 24th June 2021
Vaccines are to be made mandatory for all those working in a care home setting in England.
Insights- 21st May 2021
We set out some suggested tips for earlier-stage life sciences businesses.